A breakthrough in the treatment of empyema: what we have learnt 50 years on from Tillett and Sherry’s original case report

[摘要] The scientists William S. Tillett and Sol Sherry were responsible for the introduction of intrapleural fibrinolytics as therapeutic agents, thus supplementing antimicrobial therapy in the treatment of empyema. They were the first to suggest the possibility that the use of these drugs in empyema might obviate the need for radical surgical procedures. This article highlights their original work and contributions in this field.

[学科分类] 传染病学

[关键词] Empyema;intrapleural fibrinolytics